{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T01:16:14Z","timestamp":1648948574539},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Compr Ther"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1007\/s12019-000-0031-8","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T12:58:38Z","timestamp":1179147518000},"page":"283-293","source":"Crossref","is-referenced-by-count":2,"title":["An update on community-acquired pneumonia in adults"],"prefix":"10.1007","volume":"26","author":[{"given":"Mark","family":"Gotfried","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collin","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","volume":"31","author":"JG Barlett","year":"2000","unstructured":"Barlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31:347\u2013382.","journal-title":"Clin Infect Dis."},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2105\/AJPH.76.7.761","volume":"76","author":"WH Basker","year":"1986","unstructured":"Basker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970\u201378. Am J Public Health. 1986;76:761\u2013765.","journal-title":"Am J Public Health."},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/148.5.1418","volume":"148","author":"MS Niederman","year":"1993","unstructured":"Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418\u20131426.","journal-title":"Am Rev Respir Dis."},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/18.4.501","volume":"18","author":"TJ Marrie","year":"1994","unstructured":"Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501\u2013515.","journal-title":"Clin Infect Dis."},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","volume":"275","author":"MJ Fine","year":"1996","unstructured":"Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134\u2013141.","journal-title":"JAMA"},{"key":"31_CR6","first-page":"298","volume":"47","author":"DR Mehr","year":"1998","unstructured":"Mehr DR, Zweig SC, Kruse RL, et al. Mortality from lower respiratory infection in nursing home residents. J Fam Pract. 1998;47:298\u2013304.","journal-title":"J Fam Pract."},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/archinte.1997.00440400040005","volume":"157","author":"MS Houston","year":"1997","unstructured":"Houston MS, Silverstein MD, Suman VJ. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Arch Intern Med. 1997;157:2190\u20132195.","journal-title":"Arch Intern Med."},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1164\/ajrccm.154.5.8912763","volume":"154","author":"R Riquelme","year":"1996","unstructured":"Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med. 1996;154:1450\u20131455.","journal-title":"Am J Respir Crit Care Med."},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(98)02239-9","volume":"352","author":"PD Brown","year":"1998","unstructured":"Brown PD, Lerner SA. Community-acquired pneumonia. Lancet. 1998;352:1295\u20131302.","journal-title":"Lancet."},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archinte.1997.00440340089009","volume":"157","author":"JP Metlay","year":"1997","unstructured":"Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157:1453\u20131459.","journal-title":"Arch Intern Med."},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1378\/chest.81.6.672","volume":"81","author":"RE Thacker","year":"1982","unstructured":"Thacker RE, Kraman SS. The prevalence of auscultatory crackles in subjects without lung disease. Chest. 1982;81:672\u2013674.","journal-title":"Chest."},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.1997.03550170070035","volume":"278","author":"JP Metlay","year":"1997","unstructured":"Metlay JP, Kapoor WN, Fine MJ. Does this patient have Community-acquired pneumonia? Diagnosing pneumonia by history and physical exam. JAMA. 1997;278:1440\u20131445.","journal-title":"JAMA"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1001\/archinte.1996.00440180068008","volume":"156","author":"PB Hasley","year":"1996","unstructured":"Hasley PB, Albaum MN, Li Y, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia. Arch Intern Med. 1996;156:2206\u20132212.","journal-title":"Arch Intern Med."},{"key":"31_CR14","first-page":"524","volume":"18","author":"GS San Pedro","year":"1997","unstructured":"San Pedro GS, Areno JP, Campbell D, Silberman R. Gram's stain and chest films: how reliable in CAP?. J Respir Dis. 1997;18:524\u2013535.","journal-title":"J Respir Dis."},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.1997.00440360129015","volume":"157","author":"BJ Marston","year":"1997","unstructured":"Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157:1709\u20131718.","journal-title":"Arch Intern Med."},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1378\/chest.103.1.232","volume":"103","author":"J Rello","year":"1993","unstructured":"Rello J, Quintana E, Ausina V, Net A, Prats G. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest. 1993;103:232\u2013235.","journal-title":"Chest."},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/thx.51.10.1010","volume":"51","author":"AM Neill","year":"1996","unstructured":"Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51:1010\u20131016.","journal-title":"Thorax."},{"key":"31_CR18","first-page":"947","volume":"45","author":"Centers for Disease Control","year":"1996","unstructured":"Centers for Disease Control. Assessment of national reporting of drug-resistant Streptococcus pneumoniae-United States, 1995\u20131996. MMWR Morb Mortal Wkly Rpt. 1996;45:947\u2013949.","journal-title":"MMWR Morb Mortal Wkly Rpt."},{"key":"31_CR19","first-page":"986","volume":"174","author":"JC Butler","year":"1996","unstructured":"Butler JC, Hofmann J, Cetron MS, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the centers for disease control and prevention's pneumococcal sentinel surveillance system. Clin Infect Dis. 1996;174:986\u2013993.","journal-title":"Clin Infect Dis."},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.1994.03510470035031","volume":"271","author":"RF Breiman","year":"1994","unstructured":"Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal isolates in the United States. JAMA. 1994;271:1831\u20131835.","journal-title":"JAMA"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0891-5520(05)70394-9","volume":"11","author":"RJ Leggiadro","year":"1997","unstructured":"Leggiadro RJ. The clinical impact of resistance in the management of pneumococcal disease. Infect Dis Clin North Am. 1997;11:867\u2013874.","journal-title":"Infect Dis Clin North Am."},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","volume":"26","author":"GD Campbell Jr.","year":"1998","unstructured":"Campbell, Jr., GD, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis. 1998;26:1188\u20131195.","journal-title":"Clin Infect Dis."},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","volume":"27","author":"GV Doern","year":"1998","unstructured":"Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27:764\u2013778.","journal-title":"Clin Infect Dis."},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.1996.03530270034028","volume":"275","author":"JF Plouffe","year":"1996","unstructured":"Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA. 1996;275:194\u2013198.","journal-title":"JAMA"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1086\/513628","volume":"24","author":"AJ Clavo-Sanchez","year":"1997","unstructured":"Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis. 1997;24:1052\u20131059.","journal-title":"Clin Infect Dis."},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00019048-199601000-00009","volume":"5","author":"MS Terpenning","year":"1996","unstructured":"Terpenning MS. The 10 most common questions about aspiration pneumonia. Infect Dis Clin Pract. 1996;5:42\u201346.","journal-title":"Infect Dis Clin Pract."},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/515218","volume":"28","author":"AM Fein","year":"1999","unstructured":"Fein AM. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis. 1999;28:726\u2013729.","journal-title":"Clin Infect Dis."},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0011-5029(98)90012-8","volume":"44","author":"HA Cassiere","year":"1998","unstructured":"Cassiere HA, Niederman MS. Community-acquired pneumonia. Dis Month. 1998;44:622\u2013675.","journal-title":"Dis Month."},{"issue":"Suppl 2","key":"31_CR29","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.108.2_Supplement.35S","volume":"108","author":"LA Mandell","year":"1995","unstructured":"Mandell LA. Community-acquired pneumonia: etiology, epidemiology, and treatment. Chest. 1995;108 (Suppl 2):35S-42S.","journal-title":"Chest."},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/clinids\/23.4.723","volume":"23","author":"J Rello","year":"1996","unstructured":"Rello J, Rodriquez R, Jubert P, Alvarez B. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. The Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis. 1996;23:723\u2013728.","journal-title":"Clin Infect Dis."},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/AAC.41.2.292","volume":"41","author":"GV Doern","year":"1997","unstructured":"Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of \u03b2-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292\u2013297.","journal-title":"Antimicrob Agents Chemother."},{"key":"31_CR32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/clinids\/22.4.632","volume":"22","author":"GM Wood","year":"1996","unstructured":"Wood GM, Johnson BC, McCormack JG. Moraxella catarrhalis: pathogenic significance in respiratory tract infections treated by community practitioners. Clin Infect Dis. 1996;22:632\u2013636.","journal-title":"Clin Infect Dis."},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinids\/11.4.586","volume":"11","author":"TJ Marrie","year":"1989","unstructured":"Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: a 5 year prospective study. Rev Infect Dis. 1989;11:586\u2013599.","journal-title":"Rev Infect Dis."},{"key":"31_CR34","first-page":"153","volume":"9","author":"J Macfarlane","year":"1994","unstructured":"Macfarlane J. An overview of community acquired pneumonia with lessons from the British Thoracic Society study. Semin Respir Infect. 1994;9:153\u2013165.","journal-title":"Semin Respir Infect."},{"key":"31_CR35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archinte.1986.00360170090015","volume":"146","author":"B Nicotra","year":"1986","unstructured":"Nicotra B, Rivera M, Luman JI, Wallace RJ Jr. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med. 1986;146:890\u2013893.","journal-title":"Arch Intern Med."},{"key":"31_CR36","first-page":"40","volume":"4","author":"PW Wright","year":"1989","unstructured":"Wright PW, Wallace RJ Jr. Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect. 1989;4:40\u201346.","journal-title":"Semin Respir Infect."},{"key":"31_CR37","first-page":"43","volume":"13","author":"BA Cunha","year":"1998","unstructured":"Cunha BA, Shea KW. Emergence of antimicrobial resistance in community-acquired pulmonary pathogens. Semin Respir Infect. 1998;13:43\u201353.","journal-title":"Semin Respir Infect."},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0891-5520(05)70199-9","volume":"12","author":"TM File Jr.","year":"1998","unstructured":"File TM Jr., Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am. 1998;12:569\u2013592.","journal-title":"Infect Dis Clin North Am."},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01713313","volume":"24","author":"D Lieberman","year":"1996","unstructured":"Lieberman D, Ben-Yaakov M, Lazarovich Z, et al. Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection. 1996;24:109\u2013114.","journal-title":"Infection."},{"key":"31_CR40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","volume":"51","author":"D Lieberman","year":"1996","unstructured":"Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax. 1996;51:179\u2013184.","journal-title":"Thorax."},{"key":"31_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000196519","volume":"63","author":"R Cosentini","year":"1996","unstructured":"Cosentini R, Blasi F, Raccanelli R, et al. Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration. 1996;63:61\u201365.","journal-title":"Respiration"},{"key":"31_CR42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinids\/23.4.671","volume":"23","author":"D Taylor-Robinson","year":"1996","unstructured":"Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis. 1996;23:671\u2013684.","journal-title":"Clin Infect Dis."},{"key":"31_CR43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0002-9343(96)00255-0","volume":"101","author":"TJ Marrie","year":"1996","unstructured":"Marrie TJ, Peeling RW, Fine MJ, Singer D, Coley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med. 1996;101:508\u2013515.","journal-title":"Am J Med."},{"key":"31_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000196557","volume":"63","author":"D Lieberman","year":"1996","unstructured":"Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community acquired pneumonia: a review of 101 hospitalized adult patients. Respiration. 1996;63:261\u2013266.","journal-title":"Respiration"},{"key":"31_CR45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clind\/16.6.741","volume":"16","author":"PH Edelstein","year":"1993","unstructured":"Edelstein PH. Legionnaire's disease. Clin Infect Dis. 1993;16:741\u2013749.","journal-title":"Clin Infect Dis."},{"key":"31_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-199346010-00005","volume":"46","author":"J Roig","year":"1993","unstructured":"Roig J, Carreres A, Domingo C. Treatment of Legionnaire's disease: current recommendations. Drugs. 1993;46:63\u201379.","journal-title":"Drugs."},{"key":"31_CR47","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1378\/chest.109.5.1243","volume":"109","author":"D Lieberman","year":"1996","unstructured":"Lieberman D, Porath A, Schlaeffer F, Lieberman D, Boldur I. Legionella species community-acquired pneumonia: a review of 56 hospitalized adult patients. Chest. 1996;109:1243\u20131249.","journal-title":"Chest."},{"key":"31_CR48","first-page":"233","volume":"15","author":"CM Herman","year":"1998","unstructured":"Herman CM, Chen J, High KP. Pneumococcal penicillin resistance and the cost-effectiveness of pneumococcal vaccine. Infect Med 1998;15:233, 236, 237, 241\u20133, 275.","journal-title":"Infect Med"},{"key":"31_CR49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.1997.03550160053038","volume":"278","author":"JE Sisk","year":"1997","unstructured":"Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;278:1333\u20131339.","journal-title":"JAMA"},{"key":"31_CR50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2165\/00002512-199608050-00003","volume":"8","author":"TJ Marrie","year":"1996","unstructured":"Marrie TJ, Slayter KL. Nursing home-acquired pneumonia: treatment options. Drugs Aging. 1996;8:338\u2013348.","journal-title":"Drugs Aging."},{"key":"31_CR51","first-page":"68","volume":"13","author":"A Niederman","year":"1998","unstructured":"Niederman A, Niederman MS. Strategies for prevention of community-acquired pneumonia. Semin Respir Infect. 1998; 13:68\u201378.","journal-title":"Semin Respir Infect."},{"key":"31_CR52","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/clinids\/21.3.616","volume":"21","author":"HB Konradsen","year":"1995","unstructured":"Konradsen HB. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis. 1995;21:616\u2013620.","journal-title":"Clin Infect Dis."},{"key":"31_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/173.2.387","volume":"173","author":"U Sankilampi","year":"1996","unstructured":"Sankilampi U, Honkanen PO, Bloigu A, Herva E, Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis. 1996;173:387\u2013393.","journal-title":"J Infect Dis."},{"key":"31_CR54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(97)07358-3","volume":"351","author":"A \u00d6rtqvist","year":"1998","unstructured":"\u00d6rtqvist A, Hedlund J, Burman LA, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 1998;351:399\u2013403.","journal-title":"Lancet"},{"key":"31_CR55","first-page":"797","volume":"47","author":"Centers for Disease Control","year":"1998","unstructured":"Centers for Disease Control. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years-United States. MMWR Morb Mortal Wkly Rpt. 1998;47:797\u2013802.","journal-title":"MMWR Morb Mortal Wkly Rpt."},{"key":"31_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00063198-199905000-00006","volume":"5","author":"DAJ Moore","year":"1999","unstructured":"Moore DAJ, Sharland M, Friedland JS. Upper respiratory tract infections. Curr Opin Pulm Med. 1999;5:157\u2013163.","journal-title":"Curr Opin Pulm Med."},{"key":"31_CR57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.282.1.31","volume":"282","author":"AS Monto","year":"1999","unstructured":"Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliott MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 1999;282:31\u201335.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"31_CR58","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/56.suppl_2.S3","volume":"56","author":"JD Grabenstein","year":"1999","unstructured":"Grabenstein JD, Bonasso J. Health-system pharmacists' role in immunizing adults against pneumococcal disease and influenza. Am J Health Syst Pharm. 1999;56(Suppl 2):S3-S22.","journal-title":"Am J Health Syst Pharm."},{"key":"31_CR59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4065\/74.3.290","volume":"74","author":"AJ Wright","year":"1999","unstructured":"Wright AJ. The penicillins. Mayo Clin Proc. 1999;74:290\u2013307.","journal-title":"Mayo Clin Proc."},{"key":"31_CR60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.34.1.156","volume":"34","author":"DA Weber","year":"1990","unstructured":"Weber DA, Sanders CC. Diverse potential of \u03b2-lactamase inhibitors to induce class I enzymes. Antimicrob Agents Chemother. 1990;34:156\u2013158.","journal-title":"Antimicrob Agents Chemother"},{"key":"31_CR61","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/infdis\/154.5.792","volume":"154","author":"CC Sanders","year":"1986","unstructured":"Sanders CC, Sanders WE Jr. Type I \u03b2-lactamases of gramnegative bacteria: interactions with \u03b2-lactam antibiotics. J Infect Dis. 1986;154:792\u2013800.","journal-title":"J Infect Dis."},{"key":"31_CR62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.30.4.584","volume":"30","author":"F Tausk","year":"1986","unstructured":"Tausk F, Stratton CW. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1986;30:584\u2013589.","journal-title":"Antimicrob Agents Chemother"},{"key":"31_CR63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4065\/74.2.187","volume":"74","author":"WF Marshall","year":"1999","unstructured":"Marshall WF, Blair JE. The cephalosporins. Mayo Clin Proc. 1999;74:187\u2013195.","journal-title":"Mayo Clin Proc."},{"key":"31_CR64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7164\/antibiotics.32.718","volume":"32","author":"F Leitner","year":"1979","unstructured":"Leitner F, Goodhines RA, Buck FE, Price KE. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model. J Antibiot. 1979;32:718\u2013726.","journal-title":"J Antibiot."},{"key":"31_CR65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.39.2.533","volume":"39","author":"JC Fung-Tomc","year":"1995","unstructured":"Fung-Tomc JC, Huczko E, Stickle T, et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob Agents Chemother. 1995;39:533\u2013538.","journal-title":"Antimicrob Agents Chemother"},{"key":"31_CR66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/AAC.32.5.671","volume":"32","author":"NX Chin","year":"1988","unstructured":"Chin NX, Neu HC. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Antimicrob Agents Chemother. 1988;32:671\u2013677.","journal-title":"Antimicrob Agents Chemother"},{"key":"31_CR67","unstructured":"Thornsberry C, Ogilvie P, Holley HP, Jr. The susceptibility of penicillin-susceptible and-resistant S. pneumoniae to 26 antimicrobial agents [Abstract]. IDSA 35th Annual Meeting, San Francisco, 1997, Abstract 731."},{"key":"31_CR68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinids\/20.3.671","volume":"20","author":"DW Haas","year":"1995","unstructured":"Haas DW, Stratton CW, Griffin JP, Weeks L, Alts SC. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis. 1995;20:671\u2013676.","journal-title":"Clin Infect Dis."},{"key":"31_CR69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/106002809202600112","volume":"26","author":"N Bahal","year":"1992","unstructured":"Bahal N, Nahata MC. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother. 1992;26:46\u201355.","journal-title":"Ann Pharmacother"},{"key":"31_CR70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/40.1.139","volume":"40","author":"AL Barry","year":"1997","unstructured":"Barry AL, Fuchs PC, Brown SD. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother. 1997;40:139\u2013140.","journal-title":"J Antimicrob Chemother"},{"key":"31_CR71","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0025-6196(12)62479-3","volume":"66","author":"JD Smilack","year":"1991","unstructured":"Smilack JD, Wilson WR, Cockerill FR. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin Proc. 1991;66:1270\u20131280.","journal-title":"Mayo Clin Proc."},{"key":"31_CR72","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","volume":"157","author":"N Joshi","year":"1997","unstructured":"Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med. 1997;157:1421\u20131428.","journal-title":"Arch Intern Med."},{"key":"31_CR73","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0924-8579(94)90034-5","volume":"4","author":"CD Freeman","year":"1994","unstructured":"Freeman CD, Nightingale CH, Quintiliani R. Minocycline: old and new therapeutic uses. Int J Antimicrob Agents. 1994; 4:325\u2013335.","journal-title":"Int J Antimicrob Agents."},{"key":"31_CR74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0891-5520(20)30693-0","volume":"9","author":"EF Hendershot","year":"1995","unstructured":"Hendershot EF. Fluoroquinolones. Infect Dis Clin North Am. 1995;9:715\u2013730.","journal-title":"Infect Dis Clin North Am."},{"key":"31_CR75","unstructured":"Dalhoff A. Dissociated resistance among fluoroquinolones [Abstract]. 2nd European Congress of Chemotherapy 1988; Hamburg, Germany: Abstract T160."},{"key":"31_CR76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0732-8893(98)00042-X","volume":"32","author":"DJ Biedenbach","year":"1998","unstructured":"Biedenbach DJ, Barrett MS, Croco MAT, Jones RN. BAY 12-8039, a novel fluoroquinolone: activity against important respiratory tract pathogens. Diagn Microbiol Infect Dis. 1998; 32:45\u201350.","journal-title":"Diagn Microbiol Infect Dis."},{"key":"31_CR77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jac\/40.4.503","volume":"40","author":"AP MacGowan","year":"1997","unstructured":"MacGowan AP, Bowker KE, Holt HA, Wootton M, Reeves DS. Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. J Antimicrob Chemother. 1997;40:503\u2013509.","journal-title":"J Antimicrob Chemother"},{"key":"31_CR78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/13543784.8.2.123","volume":"8","author":"A Dalhoff","year":"1999","unstructured":"Dalhoff A. In vitro activities of quinolones. Exp Opin Invest Drugs. 1999;8:123\u2013137.","journal-title":"Exp Opin Invest Drugs."},{"key":"31_CR79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.8.2.181","volume":"8","author":"AP MacGowan","year":"1999","unstructured":"MacGowan AP. Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial. Exp Opin Invest Drugs. 1999;8:181\u2013199.","journal-title":"Exp Opin Invest Drugs."},{"key":"31_CR80","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.39.12.2635","volume":"39","author":"M Nakashima","year":"1995","unstructured":"Nakashima M, Uematsu T, Kosuge K, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother. 1995;39:2635\u20132640.","journal-title":"Antimicrob Agents Chemother"},{"key":"31_CR81","first-page":"346","volume":"49","author":"British Thoracic Society","year":"1993","unstructured":"British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med. 1993;49:346\u2013350.","journal-title":"Br J Hosp Med."},{"key":"31_CR82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","volume":"31","author":"LA Mandell","year":"2000","unstructured":"Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis. 2000;31:383\u2013421.","journal-title":"Clin Infect Dis."},{"issue":"Suppl","key":"31_CR83","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1378\/chest.113.3_Supplement.179S","volume":"113","author":"MS Niederman","year":"1998","unstructured":"Niederman MS. Community-acquired pneumonia: a North American perspective. Chest. 1998;113 (Suppl):179S-182S.","journal-title":"Chest."},{"issue":"Suppl","key":"31_CR84","doi-asserted-by":"crossref","first-page":"183S","DOI":"10.1378\/chest.113.3_Supplement.183S","volume":"113","author":"M Woodhead","year":"1998","unstructured":"Woodhead M. Community-acquired pneumonia guidelines\u2014an international comparison: a view from Europe. Chest. 1998;113(Suppl):183S-187S.","journal-title":"Chest."},{"key":"31_CR85","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1378\/chest.113.6.1689","volume":"113","author":"TK Marras","year":"1998","unstructured":"Marras TK, Chan CK. Use of guidelines in treating community-acquired pneumonia. Chest. 1998;113:1689\u20131694.","journal-title":"Chest."},{"key":"31_CR86","first-page":"153","volume":"9","author":"J MacFarlane","year":"1994","unstructured":"MacFarlane J. An overview of community acquired pneumonia with lessons learned from the British Thoracic Society. Semin Respir Infect. 1994;9:153\u2013165.","journal-title":"Semin Respir Infect."},{"key":"31_CR87","first-page":"52","volume":"126","author":"A Spake","year":"1999","unstructured":"Spake A. Losing the battle of the bugs. US News. 1999 May 10;126:52\u201360.","journal-title":"US News"},{"key":"31_CR88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1592\/phco.19.8.672.31520","volume":"19","author":"DM Cappelletty","year":"1999","unstructured":"Cappelletty DM. Critical pathways or treatment algorithms in infectious diseases: do they really work? Pharmacotherapy. 1999;19:672\u2013674.","journal-title":"Pharmacotherapy"}],"container-title":["Comprehensive Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-000-0031-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12019-000-0031-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12019-000-0031-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T14:33:40Z","timestamp":1628865220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12019-000-0031-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s12019-000-0031-8","relation":{},"ISSN":["0098-8243","1559-1190"],"issn-type":[{"value":"0098-8243","type":"print"},{"value":"1559-1190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}